PL2051693T3 - Kompozycja farmaceutyczna, łatwa do połknięcia i nie powodująca nieprzyjemnych odczuć w ustach, zawierająca cząstki z substancją czynną - Google Patents
Kompozycja farmaceutyczna, łatwa do połknięcia i nie powodująca nieprzyjemnych odczuć w ustach, zawierająca cząstki z substancją czynnąInfo
- Publication number
- PL2051693T3 PL2051693T3 PL07801698T PL07801698T PL2051693T3 PL 2051693 T3 PL2051693 T3 PL 2051693T3 PL 07801698 T PL07801698 T PL 07801698T PL 07801698 T PL07801698 T PL 07801698T PL 2051693 T3 PL2051693 T3 PL 2051693T3
- Authority
- PL
- Poland
- Prior art keywords
- particles
- swallow
- pharmaceutical composition
- causing
- pharmaceutical compositions
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 230000035807 sensation Effects 0.000 title 1
- 210000003296 saliva Anatomy 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06017263A EP1891936A1 (de) | 2006-08-18 | 2006-08-18 | Gut schluckbare pharmazeutische Zusammensetzung aus einem oder mehreren wirkstoffhaltigen Teilchen ohne unangenehmes Mundgefühl |
| US11/516,573 US8889184B2 (en) | 2006-09-07 | 2006-09-07 | Particulate form of a pharmaceutical composition which is easy to swallow |
| EP07801698A EP2051693B1 (en) | 2006-08-18 | 2007-08-16 | Pharmaceutical compositions easy to swallow, not causing any unpleasant oral sensation and comprising particles with an active principle |
| PCT/EP2007/007243 WO2008019854A1 (en) | 2006-08-18 | 2007-08-16 | Pharmaceutical compositions easy to swallow, not causing any unpleasant oral sensation and comprising particles with an active principle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2051693T3 true PL2051693T3 (pl) | 2011-04-29 |
Family
ID=38596162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07801698T PL2051693T3 (pl) | 2006-08-18 | 2007-08-16 | Kompozycja farmaceutyczna, łatwa do połknięcia i nie powodująca nieprzyjemnych odczuć w ustach, zawierająca cząstki z substancją czynną |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2051693B1 (pl) |
| AT (1) | ATE484275T1 (pl) |
| BR (1) | BRPI0715756B8 (pl) |
| CA (1) | CA2661575C (pl) |
| DE (1) | DE602007009846D1 (pl) |
| DK (1) | DK2051693T3 (pl) |
| PL (1) | PL2051693T3 (pl) |
| WO (1) | WO2008019854A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0908839A2 (pt) * | 2008-03-05 | 2015-08-25 | Lubrizol Advanced Mat Inc | Sistema de dispensação de droga de liberação controlada, e, composição farmacêutica de liberação controlada |
| US20110111026A1 (en) * | 2008-03-10 | 2011-05-12 | Adel Penhasi | Humidity-resistant drug formulations and methods of preparation thereof |
| EP2790729A4 (en) | 2011-12-12 | 2015-08-12 | Orbis Biosciences Inc | PARTICULATE FORMULATIONS WITH DELAYED RELEASE |
| WO2022106923A1 (en) | 2020-11-18 | 2022-05-27 | BioPharma Synergies, S. L. | Orodispersible powder composition comprising an antihistamine compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2251623C (en) * | 1996-05-13 | 2006-12-19 | Novartis Consumer Health S.A. | Buccal delivery system |
| DE59702733D1 (de) * | 1996-08-15 | 2001-01-11 | Losan Pharma Gmbh | Gut schluckbare orale arzneiform |
| WO2005105036A1 (en) * | 2004-04-28 | 2005-11-10 | Natco Pharma Limited | Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation |
-
2007
- 2007-08-16 EP EP07801698A patent/EP2051693B1/en active Active
- 2007-08-16 CA CA2661575A patent/CA2661575C/en active Active
- 2007-08-16 DK DK07801698.7T patent/DK2051693T3/da active
- 2007-08-16 DE DE602007009846T patent/DE602007009846D1/de active Active
- 2007-08-16 WO PCT/EP2007/007243 patent/WO2008019854A1/en not_active Ceased
- 2007-08-16 AT AT07801698T patent/ATE484275T1/de active
- 2007-08-16 PL PL07801698T patent/PL2051693T3/pl unknown
- 2007-08-16 BR BRPI0715756A patent/BRPI0715756B8/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2661575C (en) | 2014-06-17 |
| BRPI0715756A2 (pt) | 2013-07-09 |
| EP2051693A1 (en) | 2009-04-29 |
| DE602007009846D1 (de) | 2010-11-25 |
| BRPI0715756B1 (pt) | 2020-03-17 |
| ATE484275T1 (de) | 2010-10-15 |
| BRPI0715756B8 (pt) | 2021-05-25 |
| EP2051693B1 (en) | 2010-10-13 |
| CA2661575A1 (en) | 2008-02-21 |
| DK2051693T3 (da) | 2010-12-13 |
| WO2008019854A1 (en) | 2008-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3731699A (en) | Orally disintegrable tablets | |
| WO2008069941A3 (en) | Modified release ibuprofen solid oral dosage form | |
| MX2009005727A (es) | Nanoparticulas de entidad anfifilica. | |
| RU2009146580A (ru) | Состав, содержащий никотин, с покрытием для перорального применения с буферными свойствами, приданными аминокислотой | |
| MX2007004736A (es) | Composicion farmaceutica que comprende diclofenaco. | |
| WO2006058249A3 (en) | Methods and compositions for deterring abuse of orally administered pharmaceutical products | |
| GB0425758D0 (en) | Preparation of pharmaceutical compositions | |
| WO2005039499A3 (en) | Rapidly disintegrating film | |
| RU2008149508A (ru) | Покрытый фармацевтический продукт для доставки никотина в ротовую полость, включающий трометамол в качестве придающего буферные свойства агента | |
| MX2010006284A (es) | Formulaciones farmaceuticas de fenilefrina y composiciones para la absorcion transmucosal. | |
| SI2529622T1 (en) | Inhibitors of bruton's tyrosine kinase | |
| WO2006100075A3 (en) | Use of an artificial sweetener to enhance absorption of nicotine | |
| PL370292A1 (pl) | Preparaty | |
| WO2007106550A3 (en) | Methods and compositions for deterring abuse of orally administered pharmaceutical products | |
| MX2007006343A (es) | Forma farmaceutica multiparticulada que comprende ingredientes activos de acido nucleico mucoadhesivamente formulado y un proceso para producir la forma farmaceutica. | |
| PL2051693T3 (pl) | Kompozycja farmaceutyczna, łatwa do połknięcia i nie powodująca nieprzyjemnych odczuć w ustach, zawierająca cząstki z substancją czynną | |
| MX2010004556A (es) | Formulacion farmaceutica de acido clavulanico. | |
| WO2007128495A3 (en) | Solid pharmaceutical composition of gabapentin | |
| MA32722B1 (fr) | Formulation galénique renfermant de l'aliskirène et procédé associé de préparation par granulation par fusion-extrusion | |
| WO2003045305A3 (en) | Acetaminophen compositions | |
| WO2004037228A8 (en) | Sustained release compositions containing alfuzosin | |
| HUP0300607A3 (en) | Novel galenical composition for oral administration with prolonged release of molsidomine | |
| WO2007037790A3 (en) | Modified release famciclovir compositions | |
| DE50311479D1 (de) | Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung | |
| WO2008147245A3 (fr) | Composition pharmaceutique de proxodolol à libération contrôlée |